Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
Revenue
Adaptive Biotechnologies Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Revenue
$170.3m
|
CAGR 3-Years
20%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
See Also
What is Adaptive Biotechnologies Corp's Revenue?
Revenue
170.3m
USD
Based on the financial report for Dec 31, 2023, Adaptive Biotechnologies Corp's Revenue amounts to 170.3m USD.
What is Adaptive Biotechnologies Corp's Revenue growth rate?
Revenue CAGR 5Y
25%
Over the last year, the Revenue growth was -8%. The average annual Revenue growth rates for Adaptive Biotechnologies Corp have been 20% over the past three years , 25% over the past five years .